HEP-ART
Desconocido
BALXPAND: The HepaRG Bio Artificial Liver Feasibility of commercialization and expansion of business plan
HEPART MEDICAL DEVICES BV
tramitó un
H2020:
H2020-SMEInst-2016-2017
End-stage liver disease patients suffer from a dramatic loss of functional liver tissue, which leads to 50-80% mortality. Liver transplantat...
2017-02-04 - 2017-08-31 | Financiado
2017-02-04 - 2017-08-31 | Financiado
BALANCE: Development of a bioartificial liver therapy in acute liver failure
HEPART MEDICAL DEVICES BV
participó en un
FP7:
In BALANCE, the companies Hep-Art, Pharmacell and BioPredic join forces with academic partners Amsterdam Medical Centre and University of Ed...
Financiado
Financiado
* No se disponen de datos de la empresa actual.